Literature DB >> 10512363

Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.

L Scheja1, L Makowski, K T Uysal, S M Wiesbrock, D R Shimshek, D S Meyers, M Morgan, R A Parker, G S Hotamisligil.   

Abstract

Recent studies have shown that genetic deficiency of the adipocyte fatty acid-binding protein (aP2) results in minor alterations of plasma lipids and adipocyte development but provides significant protection from dietary obesity-induced hyperinsulinemia and insulin resistance. To identify potential mechanisms responsible for this phenotype, we examined lipolysis and insulin secretion in aP2-/- mice. Beta-adrenergic stimulation resulted in a blunted rise of blood glycerol levels in aP2-/- compared with aP2+/+ mice, suggesting diminished lipolysis in aP2-/- adipocytes. Confirming this, primary adipocytes isolated from aP2-/- mice showed attenuated glycerol and free fatty acid (FFA) release in response to dibutyryl cAMP. The decreased lipolytic response seen in the aP2-/- mice was not associated with altered expression levels of hormone-sensitive lipase or perilipin. The acute insulin secretory response to beta-adrenergic stimulation was also profoundly suppressed in aP2-/- mice despite comparable total concentrations and only minor changes in the composition of systemic FFAs. To address whether levels of specific fatty acids are different in aP2-/- mice, the plasma FFA profile after beta-adrenergic stimulation was determined. Significant reduction in both stearic and cis-11-eicoseneic acids and an increase in palmitoleic acid were observed. The response of aP2-/- mice to other insulin secretagogues such as arginine and glyburide was similar to that of aP2+/+ mice, arguing against generally impaired function of pancreatic beta-cells. Finally, no aP2 expression was detected in isolated pancreatic islet cells. These results provide support for the existence of an adipo-pancreatic axis, the proper action of which relies on the presence of aP2. Consequently, aP2's role in the pathogenesis of type 2 diabetes might involve regulation of both hyperinsulinemia and insulin resistance through its impact on both lipolysis and insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512363     DOI: 10.2337/diabetes.48.10.1987

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  56 in total

1.  Genetics and molecular biology: a role for adipocyte lipid-binding protein in atherosclerosis.

Authors:  Jheem D Medh
Journal:  Curr Opin Lipidol       Date:  2002-02       Impact factor: 4.776

Review 2.  Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses.

Authors:  Liza Makowski; Gökhan S Hotamisligil
Journal:  J Nutr       Date:  2004-09       Impact factor: 4.798

Review 3.  Heart and liver fatty acid binding proteins and the metabolic syndrome.

Authors:  Bert Binas
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

4.  Inhibitory effect of deep-sea water on differentiation of 3T3-L1 adipocytes.

Authors:  Hee Sun Hwang; Seon Hwa Kim; Yung Geun Yoo; Yong Shik Chu; Yun Hee Shon; Kyung Soo Nam; Jong Won Yun
Journal:  Mar Biotechnol (NY)       Date:  2008-07-25       Impact factor: 3.619

5.  Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome.

Authors:  Weihong Hu; Jie Qiao
Journal:  Endocrine       Date:  2011-06-22       Impact factor: 3.633

6.  Fatty acid binding protein expression in different human adipose tissue depots in relation to rates of lipolysis and insulin concentration in obese individuals.

Authors:  R M Fisher; A Thörne; A Hamsten; P Arner
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

7.  Common FABP4 genetic variants and plasma levels of fatty acid binding protein 4 in older adults.

Authors:  Kenneth J Mukamal; Jemma B Wilk; Mary L Biggs; Majken K Jensen; Joachim H Ix; Jorge R Kizer; Russell P Tracy; Susan J Zieman; Dariush Mozaffarian; Bruce M Psaty; David S Siscovick; Luc Djoussé
Journal:  Lipids       Date:  2013-09-17       Impact factor: 1.880

8.  Mapping of the hormone-sensitive lipase binding site on the adipocyte fatty acid-binding protein (AFABP). Identification of the charge quartet on the AFABP/aP2 helix-turn-helix domain.

Authors:  Anne J Smith; Mark A Sanders; Brittany E Juhlmann; Ann V Hertzel; David A Bernlohr
Journal:  J Biol Chem       Date:  2008-09-27       Impact factor: 5.157

9.  Circulating FABP4 and FABP5 levels are differently linked to OSA severity and treatment.

Authors:  Raquel Català; Anna Cabré; Salvador Hernández-Flix; Raimón Ferré; Sandra Sangenís; Núria Plana; Anna Texidó; Lluís Masana
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

10.  Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.

Authors:  Jeffrey B Boord; Kazuhisa Maeda; Liza Makowski; Vladimir R Babaev; Sergio Fazio; MacRae F Linton; Gökhan S Hotamisligil
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.